Share Price and Basic Stock Data
Last Updated: December 26, 2025, 9:07 pm
| PEG Ratio | 2.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ICRA Ltd operates within the rating services industry, providing vital credit ratings and research services. The company reported a sales figure of ₹403 Cr for the fiscal year ending March 2023, which rose to ₹446 Cr in March 2024 and is projected to reach ₹498 Cr in March 2025. This demonstrates a healthy year-on-year growth trajectory. In the most recent quarter ending June 2024, ICRA recorded sales of ₹115 Cr, with a slight decline to ₹124 Cr by March 2025. The quarterly sales figures reflect an upward trend over the past year, with the quarterly sales increasing from ₹103 Cr in June 2023 to ₹115 Cr in June 2024. This consistent growth in revenue suggests a robust demand for ICRA’s services and a solid market position in the credit rating sector.
Profitability and Efficiency Metrics
ICRA Ltd’s profitability metrics highlight its operational efficiency and financial health. The company recorded a net profit of ₹137 Cr for the fiscal year ending March 2023, which increased to ₹152 Cr in March 2024 and is expected to reach ₹171 Cr by March 2025. The operating profit margin (OPM) stood at 35% for the year ending March 2023, slightly declining to 33% for March 2024 but rebounding to 36% in March 2025. Additionally, ICRA’s return on equity (ROE) was reported at 16.8%, while the return on capital employed (ROCE) stood at 23.1%, both indicating strong profitability relative to shareholder equity and overall capital use. The interest coverage ratio (ICR) of 53.12x showcases the company’s ability to meet its interest obligations comfortably, reflecting a solid operational foundation.
Balance Sheet Strength and Financial Ratios
ICRA Ltd’s balance sheet exhibits a strong financial position, with total assets of ₹1,292 Cr as of March 2025. The company reported reserves of ₹1,078 Cr, which indicates a substantial equity base relative to its borrowings of merely ₹12 Cr, underscoring a low debt burden and financial stability. The current ratio stands at 6.37, significantly above the typical sector benchmark of 1.5, indicating excellent liquidity. Furthermore, the price-to-book value (P/BV) ratio of 5.06x suggests that the market values ICRA’s shares at a premium, reflecting investor confidence. The enterprise value (EV) of ₹5,054.70 Cr, in relation to its net operating revenue, illustrates a healthy valuation compared to earnings, with an EV/EBITDA ratio of 19.81x indicating reasonable market expectations for growth.
Shareholding Pattern and Investor Confidence
ICRA Ltd’s shareholding structure reveals a diverse ownership base, with promoters holding 51.86% of the company, indicating a stable controlling interest. Foreign Institutional Investors (FIIs) accounted for 6.87% of the total shares, while Domestic Institutional Investors (DIIs) held 26.15%. The percentage of public shareholders stands at 14.82%, reflecting a broad base of retail investors. Over the recent quarters, the number of shareholders increased from 16,684 in December 2022 to 21,818 by September 2025, demonstrating growing investor interest. The dividend payout ratio for March 2025 is reported at 56.58%, which signals a commitment to returning profits to shareholders, further enhancing investor confidence in ICRA’s long-term sustainability and growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, ICRA Ltd appears well-positioned for continued growth, supported by its strong financial metrics and a solid reputation in the rating services industry. However, potential risks include fluctuations in economic conditions that could impact the demand for credit ratings, as well as competitive pressures from other players in the market. Additionally, reliance on a stable regulatory environment is crucial for ICRA’s operations. Should the economic outlook remain favorable, the company may capitalize on expanding opportunities in the financial sector, driving further revenue growth. Conversely, adverse regulatory changes or economic downturns could pose significant challenges. Overall, ICRA’s current financial health suggests a resilient company capable of navigating both opportunities and risks in the evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 5,930 Cr. | 6,136 | 7,135/5,015 | 31.5 | 1,127 | 0.98 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,818 Cr. | 1,604 | 1,965/1,052 | 31.5 | 288 | 1.12 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,374.00 Cr | 3,870.00 | 31.50 | 707.50 | 1.05% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93 | 99 | 103 | 109 | 103 | 105 | 115 | 124 | 115 | 126 | 121 | 136 | 124 |
| Expenses | 61 | 63 | 67 | 71 | 68 | 71 | 84 | 74 | 80 | 85 | 79 | 77 | 85 |
| Operating Profit | 32 | 36 | 36 | 38 | 35 | 34 | 30 | 50 | 35 | 41 | 42 | 59 | 40 |
| OPM % | 34% | 36% | 35% | 35% | 34% | 32% | 26% | 40% | 31% | 33% | 35% | 43% | 32% |
| Other Income | 7 | 13 | 15 | 16 | 18 | 16 | 17 | 24 | 18 | 20 | 19 | 21 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 2 | 0 | 1 | 1 | 2 |
| Depreciation | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 36 | 46 | 48 | 51 | 50 | 47 | 41 | 62 | 47 | 57 | 56 | 74 | 58 |
| Tax % | 41% | 19% | 18% | 24% | 18% | 32% | 20% | 24% | 24% | 35% | 24% | 24% | 27% |
| Net Profit | 22 | 37 | 39 | 39 | 41 | 32 | 32 | 47 | 36 | 37 | 42 | 56 | 43 |
| EPS in Rs | 22.02 | 38.06 | 40.29 | 39.76 | 41.77 | 32.92 | 33.31 | 48.56 | 36.80 | 38.05 | 43.55 | 57.75 | 43.97 |
Last Updated: August 1, 2025, 7:45 pm
Below is a detailed analysis of the quarterly data for ICRA Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 12.00 Cr..
- For Expenses, as of Jun 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 8.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 32.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 32.00%, marking a decrease of 11.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 16.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 27.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 43.97. The value appears to be declining and may need further review. It has decreased from 57.75 (Mar 2025) to 43.97, marking a decrease of 13.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 283 | 322 | 341 | 333 | 309 | 328 | 321 | 301 | 343 | 403 | 446 | 498 | 518 |
| Expenses | 197 | 252 | 240 | 231 | 194 | 215 | 225 | 220 | 222 | 260 | 297 | 320 | 329 |
| Operating Profit | 86 | 70 | 101 | 102 | 115 | 113 | 96 | 81 | 121 | 143 | 149 | 178 | 190 |
| OPM % | 30% | 22% | 30% | 31% | 37% | 34% | 30% | 27% | 35% | 35% | 33% | 36% | 37% |
| Other Income | 19 | 42 | 27 | 39 | 49 | 45 | 48 | 43 | 41 | 50 | 75 | 77 | 85 |
| Interest | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 10 | 5 | 5 |
| Depreciation | 6 | 10 | 10 | 9 | 8 | 6 | 10 | 10 | 8 | 10 | 13 | 16 | 17 |
| Profit before tax | 98 | 100 | 118 | 132 | 157 | 152 | 131 | 112 | 152 | 181 | 200 | 234 | 253 |
| Tax % | 30% | 35% | 35% | 33% | 35% | 30% | 26% | 26% | 25% | 25% | 24% | 27% | |
| Net Profit | 69 | 66 | 76 | 89 | 101 | 106 | 97 | 83 | 114 | 137 | 152 | 171 | 189 |
| EPS in Rs | 68.93 | 65.45 | 76.24 | 89.29 | 101.68 | 109.21 | 99.66 | 84.61 | 116.35 | 140.13 | 156.55 | 176.15 | 194.81 |
| Dividend Payout % | 33% | 37% | 33% | 30% | 29% | 27% | 27% | 32% | 24% | 93% | 64% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.35% | 15.15% | 17.11% | 13.48% | 4.95% | -8.49% | -14.43% | 37.35% | 20.18% | 10.95% | 12.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.50% | 1.95% | -3.62% | -8.53% | -13.44% | -5.94% | 51.78% | -17.17% | -9.23% | 1.55% |
ICRA Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 15% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 6:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 378 | 419 | 466 | 539 | 645 | 631 | 692 | 748 | 834 | 941 | 967 | 1,044 | 1,078 |
| Borrowings | 16 | 10 | 0 | 0 | 0 | 0 | 0 | 17 | 14 | 13 | 13 | 13 | 12 |
| Other Liabilities | 109 | 144 | 151 | 111 | 116 | 128 | 144 | 121 | 121 | 138 | 195 | 225 | 265 |
| Total Liabilities | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
| Fixed Assets | 89 | 91 | 92 | 37 | 36 | 34 | 54 | 46 | 46 | 47 | 91 | 90 | 90 |
| CWIP | 7 | 0 | 1 | 1 | 0 | 1 | 2 | 3 | 2 | 1 | 1 | 4 | 0 |
| Investments | 277 | 257 | 185 | 311 | 338 | 182 | 104 | 177 | 454 | 689 | 813 | 773 | 911 |
| Other Assets | 140 | 234 | 350 | 312 | 396 | 552 | 685 | 669 | 478 | 364 | 278 | 426 | 363 |
| Total Assets | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
Below is a detailed analysis of the balance sheet data for ICRA Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,078.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,044.00 Cr. (Mar 2025) to 1,078.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 265.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 225.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 40.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,364.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 90.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Sep 2025, the value is 911.00 Cr.. The value appears strong and on an upward trend. It has increased from 773.00 Cr. (Mar 2025) to 911.00 Cr., marking an increase of 138.00 Cr..
- For Other Assets, as of Sep 2025, the value is 363.00 Cr.. The value appears to be declining and may need further review. It has decreased from 426.00 Cr. (Mar 2025) to 363.00 Cr., marking a decrease of 63.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
Notably, the Reserves (1,078.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 60.00 | 101.00 | 102.00 | 115.00 | 113.00 | 96.00 | 64.00 | 107.00 | 130.00 | 136.00 | 165.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Working Capital Days | -54 | -64 | -66 | -45 | -41 | -44 | -2 | -48 | -55 | -64 | -61 | -75 |
| ROCE % | 23% | 21% | 24% | 26% | 25% | 23% | 20% | 15% | 19% | 20% | 21% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 626,192 | 0.57 | 388.11 | N/A | N/A | N/A |
| Parag Parikh Flexi Cap Fund | 287,393 | 0.14 | 178.13 | 422,587 | 2025-12-08 03:45:20 | -31.99% |
| Canara Robeco Small Cap Fund | 217,766 | 1.03 | 134.97 | 168,320 | 2025-12-08 03:45:20 | 29.38% |
| Aditya Birla Sun Life MNC Fund | 161,517 | 2.76 | 100.11 | 161,756 | 2025-12-15 02:45:37 | -0.15% |
| SBI Banking & Financial Services Fund | 153,760 | 0.97 | 95.3 | N/A | N/A | N/A |
| SBI Infrastructure Fund | 125,000 | 1.62 | 77.48 | N/A | N/A | N/A |
| JM Flexicap Fund | 119,873 | 1.24 | 74.3 | 121,828 | 2025-12-14 03:26:00 | -1.6% |
| ICICI Prudential Smallcap Fund | 80,067 | 0.59 | 49.63 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 20,972 | 0.91 | 13 | N/A | N/A | N/A |
| Parag Parikh ELSS Tax Saver Fund | 5,803 | 0.06 | 3.6 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 176.73 | 157.07 | 140.59 | 116.74 | 84.89 |
| Diluted EPS (Rs.) | 176.50 | 156.99 | 140.59 | 116.74 | 84.89 |
| Cash EPS (Rs.) | 194.38 | 171.69 | 151.85 | 125.73 | 95.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Revenue From Operations / Share (Rs.) | 516.02 | 462.24 | 417.80 | 355.19 | 311.94 |
| PBDIT / Share (Rs.) | 264.39 | 231.82 | 199.41 | 167.29 | 128.46 |
| PBIT / Share (Rs.) | 247.40 | 217.87 | 189.23 | 159.20 | 118.18 |
| PBT / Share (Rs.) | 242.43 | 207.08 | 187.77 | 157.58 | 116.05 |
| Net Profit / Share (Rs.) | 177.39 | 157.74 | 141.67 | 117.64 | 85.67 |
| NP After MI And SOA / Share (Rs.) | 176.15 | 156.56 | 140.12 | 116.35 | 84.61 |
| PBDIT Margin (%) | 51.23 | 50.15 | 47.72 | 47.09 | 41.18 |
| PBIT Margin (%) | 47.94 | 47.13 | 45.29 | 44.82 | 37.88 |
| PBT Margin (%) | 46.98 | 44.80 | 44.94 | 44.36 | 37.20 |
| Net Profit Margin (%) | 34.37 | 34.12 | 33.90 | 33.11 | 27.46 |
| NP After MI And SOA Margin (%) | 34.13 | 33.86 | 33.53 | 32.75 | 27.12 |
| Return on Networth / Equity (%) | 16.14 | 15.47 | 14.23 | 13.31 | 10.77 |
| Return on Capital Employeed (%) | 21.37 | 20.30 | 18.84 | 17.80 | 14.62 |
| Return On Assets (%) | 13.13 | 12.72 | 12.28 | 11.47 | 9.11 |
| Asset Turnover Ratio (%) | 0.40 | 0.38 | 0.24 | 0.23 | 0.23 |
| Current Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Quick Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Dividend Payout Ratio (NP) (%) | 56.58 | 82.76 | 19.91 | 23.12 | 31.80 |
| Dividend Payout Ratio (CP) (%) | 51.60 | 75.99 | 18.56 | 21.62 | 28.36 |
| Earning Retention Ratio (%) | 43.42 | 17.24 | 80.09 | 76.88 | 68.20 |
| Cash Earning Retention Ratio (%) | 48.40 | 24.01 | 81.44 | 78.38 | 71.64 |
| Interest Coverage Ratio (X) | 53.12 | 21.50 | 136.25 | 103.41 | 60.27 |
| Interest Coverage Ratio (Post Tax) (X) | 36.64 | 15.63 | 97.80 | 73.71 | 41.19 |
| Enterprise Value (Cr.) | 5054.70 | 5105.59 | 4025.55 | 3803.03 | 2773.34 |
| EV / Net Operating Revenue (X) | 10.15 | 11.44 | 9.98 | 11.09 | 9.21 |
| EV / EBITDA (X) | 19.81 | 22.82 | 20.92 | 23.55 | 22.37 |
| MarketCap / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| Retention Ratios (%) | 43.41 | 17.23 | 80.08 | 76.87 | 68.19 |
| Price / BV (X) | 5.06 | 5.38 | 4.49 | 4.87 | 4.18 |
| Price / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
After reviewing the key financial ratios for ICRA Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 176.73. This value is within the healthy range. It has increased from 157.07 (Mar 24) to 176.73, marking an increase of 19.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 176.50. This value is within the healthy range. It has increased from 156.99 (Mar 24) to 176.50, marking an increase of 19.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 194.38. This value is within the healthy range. It has increased from 171.69 (Mar 24) to 194.38, marking an increase of 22.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 516.02. It has increased from 462.24 (Mar 24) to 516.02, marking an increase of 53.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 264.39. This value is within the healthy range. It has increased from 231.82 (Mar 24) to 264.39, marking an increase of 32.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.40. This value is within the healthy range. It has increased from 217.87 (Mar 24) to 247.40, marking an increase of 29.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 242.43. This value is within the healthy range. It has increased from 207.08 (Mar 24) to 242.43, marking an increase of 35.35.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 177.39. This value is within the healthy range. It has increased from 157.74 (Mar 24) to 177.39, marking an increase of 19.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 176.15. This value is within the healthy range. It has increased from 156.56 (Mar 24) to 176.15, marking an increase of 19.59.
- For PBDIT Margin (%), as of Mar 25, the value is 51.23. This value is within the healthy range. It has increased from 50.15 (Mar 24) to 51.23, marking an increase of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 47.94. This value exceeds the healthy maximum of 20. It has increased from 47.13 (Mar 24) to 47.94, marking an increase of 0.81.
- For PBT Margin (%), as of Mar 25, the value is 46.98. This value is within the healthy range. It has increased from 44.80 (Mar 24) to 46.98, marking an increase of 2.18.
- For Net Profit Margin (%), as of Mar 25, the value is 34.37. This value exceeds the healthy maximum of 10. It has increased from 34.12 (Mar 24) to 34.37, marking an increase of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.13. This value exceeds the healthy maximum of 20. It has increased from 33.86 (Mar 24) to 34.13, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has increased from 15.47 (Mar 24) to 16.14, marking an increase of 0.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.37. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 21.37, marking an increase of 1.07.
- For Return On Assets (%), as of Mar 25, the value is 13.13. This value is within the healthy range. It has increased from 12.72 (Mar 24) to 13.13, marking an increase of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.38 (Mar 24) to 0.40, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Quick Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 2. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 56.58. This value exceeds the healthy maximum of 50. It has decreased from 82.76 (Mar 24) to 56.58, marking a decrease of 26.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 51.60. This value exceeds the healthy maximum of 50. It has decreased from 75.99 (Mar 24) to 51.60, marking a decrease of 24.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 43.42. This value is within the healthy range. It has increased from 17.24 (Mar 24) to 43.42, marking an increase of 26.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 48.40. This value is within the healthy range. It has increased from 24.01 (Mar 24) to 48.40, marking an increase of 24.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.12. This value is within the healthy range. It has increased from 21.50 (Mar 24) to 53.12, marking an increase of 31.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.64. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 36.64, marking an increase of 21.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,054.70. It has decreased from 5,105.59 (Mar 24) to 5,054.70, marking a decrease of 50.89.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.15. This value exceeds the healthy maximum of 3. It has decreased from 11.44 (Mar 24) to 10.15, marking a decrease of 1.29.
- For EV / EBITDA (X), as of Mar 25, the value is 19.81. This value exceeds the healthy maximum of 15. It has decreased from 22.82 (Mar 24) to 19.81, marking a decrease of 3.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For Retention Ratios (%), as of Mar 25, the value is 43.41. This value is within the healthy range. It has increased from 17.23 (Mar 24) to 43.41, marking an increase of 26.18.
- For Price / BV (X), as of Mar 25, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.38 (Mar 24) to 5.06, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ICRA Ltd:
- Net Profit Margin: 34.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.37% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.14% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 36.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.5 (Industry average Stock P/E: 31.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | B-710, Statesman House, New Delhi Delhi 110001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Palamadai Sundararajan Jayakumar | Non Exe.Chairman&Ind.Director |
| Mr. Ramnath Krishnan | Managing Director & Group CEO |
| Ms. Wendy Huay Huay Cheong | Non Exe.Non Ind.Director |
| Ms. Shivani Priya Mohini Kak | Non Exe.Non Ind.Director |
| Mr. Stephen Arthur Long | Non Exe.Non Ind.Director |
| Mr. Brian Joseph Cahill | Non Exe.Non Ind.Director |
| Mr. Pradip Kanakia | Independent Director |
| Ms. Anuranjita Kumar | Independent Director |
FAQ
What is the intrinsic value of ICRA Ltd?
ICRA Ltd's intrinsic value (as of 26 December 2025) is 4818.03 which is 21.48% lower the current market price of 6,136.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,930 Cr. market cap, FY2025-2026 high/low of 7,135/5,015, reserves of ₹1,078 Cr, and liabilities of 1,364 Cr.
What is the Market Cap of ICRA Ltd?
The Market Cap of ICRA Ltd is 5,930 Cr..
What is the current Stock Price of ICRA Ltd as on 26 December 2025?
The current stock price of ICRA Ltd as on 26 December 2025 is 6,136.
What is the High / Low of ICRA Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ICRA Ltd stocks is 7,135/5,015.
What is the Stock P/E of ICRA Ltd?
The Stock P/E of ICRA Ltd is 31.5.
What is the Book Value of ICRA Ltd?
The Book Value of ICRA Ltd is 1,127.
What is the Dividend Yield of ICRA Ltd?
The Dividend Yield of ICRA Ltd is 0.98 %.
What is the ROCE of ICRA Ltd?
The ROCE of ICRA Ltd is 23.1 %.
What is the ROE of ICRA Ltd?
The ROE of ICRA Ltd is 16.8 %.
What is the Face Value of ICRA Ltd?
The Face Value of ICRA Ltd is 10.0.